RxDoctor Payments Data

Peter Milgrom

Dental Public Health · Seattle, WANPI 1407939689

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $291,606 of the $305,696 with a category attached, or 95.4%. Every reported general payment came from a single manufacturer, Elevate Oral Care. Reporting peaked in 2022 at $151,440 and has fallen 91.3% since, to $13,145 in 2025.

$305,696in general payments, 2019–2025

Across 55 payments — averaging $5558.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Elevate Oral Care$306K
$429,424in research payments, 2019–2025

Across 64 payments — averaging $6709.74 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Elevate Oral Care$429K

What the payments were for

  • Consulting fees$13,1454%
  • Speaking & faculty fees$291,60695%
  • Travel & lodging$9300%
  • Food & beverage$150%

General payments by program year

20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Elevate Oral Care55$305,696

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few dental public health providers in Washingtonto place this figure against a meaningful peer group, so we don't.

Other dental public health in Seattle

See the full list for Washington →

Where these figures come from

Is this you, or does something look wrong? →